Sweden
· Delayed Price · Currency is SEK Vaxxa AB Statistics
Total Valuation
Vaxxa AB has a market cap or net worth of SEK 35.56 million. The enterprise value is 25.78 million.
| Market Cap | 35.56M |
| Enterprise Value | 25.78M |
Important Dates
The next estimated earnings date is Wednesday, April 23, 2025.
| Earnings Date | Apr 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Vaxxa AB has 43.37 million shares outstanding. The number of shares has increased by 52.28% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 43.37M |
| Shares Change (YoY) | +52.28% |
| Shares Change (QoQ) | +6.17% |
| Owned by Insiders (%) | 3.34% |
| Owned by Institutions (%) | n/a |
| Float | 41.92M |
Valuation Ratios
The trailing PE ratio is 82.00.
| PE Ratio | 82.00 |
| Forward PE | n/a |
| PS Ratio | 0.45 |
| PB Ratio | 1.80 |
| P/TBV Ratio | 2.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 66.43 |
| EV / Sales | 0.32 |
| EV / EBITDA | 10.96 |
| EV / EBIT | 86.20 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.10, with a Debt / Equity ratio of 0.02.
| Current Ratio | 2.10 |
| Quick Ratio | 2.08 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.20 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 2.60% and return on invested capital (ROIC) is 1.22%.
| Return on Equity (ROE) | 2.60% |
| Return on Assets (ROA) | 0.82% |
| Return on Invested Capital (ROIC) | 1.22% |
| Return on Capital Employed (ROCE) | 1.48% |
| Revenue Per Employee | 9.95M |
| Profits Per Employee | 48,500 |
| Employee Count | 8 |
| Asset Turnover | 3.49 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.80% in the last 52 weeks. The beta is 0.47, so Vaxxa AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | -7.80% |
| 50-Day Moving Average | 0.93 |
| 200-Day Moving Average | 1.19 |
| Relative Strength Index (RSI) | 43.57 |
| Average Volume (20 Days) | 59,057 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vaxxa AB had revenue of SEK 79.57 million and earned 388,000 in profits. Earnings per share was 0.01.
| Revenue | 79.57M |
| Gross Profit | 2.00M |
| Operating Income | 299,000 |
| Pretax Income | 388,000 |
| Net Income | 388,000 |
| EBITDA | 2.35M |
| EBIT | 299,000 |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 10.25 million in cash and 460,000 in debt, giving a net cash position of 9.79 million or 0.23 per share.
| Cash & Cash Equivalents | 10.25M |
| Total Debt | 460,000 |
| Net Cash | 9.79M |
| Net Cash Per Share | 0.23 |
| Equity (Book Value) | 19.78M |
| Book Value Per Share | 0.53 |
| Working Capital | 8.36M |
Cash Flow
| Operating Cash Flow | -2.95M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 2.51%, with operating and profit margins of 0.38% and 0.49%.
| Gross Margin | 2.51% |
| Operating Margin | 0.38% |
| Pretax Margin | 0.49% |
| Profit Margin | 0.49% |
| EBITDA Margin | 2.96% |
| EBIT Margin | 0.38% |
| FCF Margin | n/a |
Dividends & Yields
Vaxxa AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -52.28% |
| Shareholder Yield | -52.28% |
| Earnings Yield | 1.09% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on March 14, 2024. It was a reverse split with a ratio of 0.01.
| Last Split Date | Mar 14, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.01 |
Scores
Vaxxa AB has an Altman Z-Score of 6.83.
| Altman Z-Score | 6.83 |
| Piotroski F-Score | n/a |